Skip to content

Clinical trials

Terminated Phase 1 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Status: Terminated Country / region: Netherlands Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20081
20092
20103
20116
20122
20134
201410
20156
20168
20176
201810
201914
202020
202110
202211
20235
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated125

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
Amgen8
GlaxoSmithKline6
Boehringer Ingelheim5
Sanofi4
The Netherlands Cancer Institute4
Adaptimmune3
Bristol-Myers Squibb3
Hoffmann-La Roche3
Amsterdam UMC, location VUmc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms16
Carcinoma, Non-Small-Cell Lung11
Colorectal Neoplasms6
Leukemia, Myeloid, Acute6
Neoplasm Metastasis6
Amyotrophic Lateral Sclerosis5
Prostatic Neoplasms5
Pancreatic Neoplasms4
Glioblastoma3
Liposarcoma, Myxoid3

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.